Anil P. Ranganath - 25 Nov 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
25 Nov 2025
Transactions value $
-$154,020
Form type
4
Filing time
26 Nov 2025, 16:30:07 UTC
Previous filing
10 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ranganath Anil P. Senior Vice President, General Counsel and Secretary C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER By: /s/ Gerardo Hernandez, Attorney-in-Fact 26 Nov 2025 0001980144

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $282K +3K +21.5% $93.88 17K 25 Nov 2025 Direct
transaction TMDX Common Stock Sale -$436K -3K -17.69% $145.22 14K 25 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3K -28.79% $0.00 7.42K 25 Nov 2025 Common Stock 3K $93.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Remarks:

Senior Vice President, General Counsel and Secretary